The treatment failed a clinical trial and is no longer under development. It is an experimental therapy that was developed by Amicus Therapeutics to treat Gaucher disease.Reference standards of Isofagomine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Isofagomine
Catalogue No.:PA 09 83000
CAS :
Molecular Formula : C6H13NO3
Molecular Weight : 147.17
Benzyl 2,3-O-[(1S,2S)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-a-L-xylopyranoside
Catalogue No.:PA 09 0831000
Molecular Formula : C18H26O7
Molecular Weight : 354.4
Benzyl 2,3-O-[(1S,2S)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-4-nitrobenzoyl-α-L-xylopyranoside
Catalogue No.:PA 09 0831001
Molecular Formula : C25H29NO10
Molecular Weight : 503.5
(2S,3S,4aR,8R,8aR)-Octahydro-2,3-dimethoxy-2,3-dimethyl-1,4-dioxino[2,3-c]pyridine-8-methanol
Catalogue No.:PA 09 0831002
Molecular Formula : C12H23NO5
Molecular Weight : 261.32
D-4-epi-Fagomine
Catalogue No.:PA 09 0831003
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
